DOP86: FOod Additives on the Mucosal barrier study (FOAM): Effect of five emulsifiers on inflammation, intestinal permeability, and the microbiome: preliminary results.ECCO'24Year: 2024
Authors: Wellens, J.(1,2)*;Vanderstappen, J.(1);Hoekx, S.(1);Vissers, E.(2);Luppens, M.(1);Raes, J.(3,4);Verstockt, B.(1,5);Ferrante, M.(1,2);Verbeke, K.(2);Matthys, C.(6,7);Vermeire, S.(1,2);Sabino, J.(1,2);
(1)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)Translational Research Center for Gastrointestinal Disorders TARGID- KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)Rega Institute- KU Leuven, Microbiology- Immunology and Transplantation Department, Leuven, Belgium;(4)Vlaams instituut voor biotechnologie VIB, Center For Microbiology, Leuven, Belgium;(5)Translational Research Center for Gastrointestinal Disorders TARGID, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(6)Clinical and Experimental Endocrinology- KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(7)University Hospitals Leuven, Department of Endocrinology, Leuven, Belgium;
DOP87: Characterization of pathologic fibroblast and macrophage cell populations in colonic Crohn’s Disease with spatial transcriptomics.ECCO'24Year: 2024
Authors: Gudiño, V.(1,2)*;Acera, M.(3);Corraliza, A.M.(1,2);Garrido-Trigo, A.(1,2);Sanzo, Á.(1,2);Heyn, H.(4);Mereu, E.(3);Salas, A.(1,2);
(1)Institut d’Investigacions Biomèdiques August Pi i Sunyer FCRB-IDIBAPS, Inflammatory Bowel Disease Unit, Barcelona, Spain;(2)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Ciberehd, Madrid, Spain;(3)Josep Carreras Leukaemia Research Institute IJC, Cellular systems genomics, Barcelona, Spain;(4)National Centre for Genomic Analysis CNAG, Single cell genomics, Barcelona, Spain;
DOP88: Lipids drive myofibroblast activation and the epithelial-mesenchymal transition process in Crohn’s Disease.ECCO'24Year: 2024
Authors: Rizzo, G.(1)*;Wozny, M.(2);Pineda Chavez, S.E.(2);Mori, G.(1);Carriles Linares, A.(2);Morosi, L.(3,4);Martano, G.(4,5);Ghisletti, S.M.L.(6);Gandolfi, F.(6);Vallelonga, V.(6);Loy, L.(7);Bezzio, C.(7);Spaggiari, P.(8);Dal Buono, A.(7);Gabbiadini, R.(7);Carvello, M.(9);Spinelli, A.(2);Repici, A.(2,10);Armuzzi, A.(2,7);Vetrano, S.(1,2);
(1)IRCCS Humanitas Research Hospital, Laboratory of Gastrointestinal Immunopathology- Department of Gastroenterology, Rozzano- Milan, Italy;(2)Humanitas University, Department of Biomedical Sciences, Pieve Emanuele- Milan, Italy;(3)IRCCS Humanitas Research Hospital, Laboratory of Cancer Pharmacology, Rozzano- Milan, Italy;(4)IRCCS Humanitas Research Hospital, Metabolomics Unit, Rozzano- Milan, Italy;(5)CNR, Institute of Neuroscience, Milan, Italy;(6)European Institute of Oncology IEO IRCCS, Department of Experimental Oncology, Milan, Italy;(7)IRCCS Humanitas Research Hospital, IBD Unit- Department of Gastroenterology, Rozzano- Milan, Italy;(8)Humanitas Clinical and Research Center-IRCCS, Department of Pathology, Rozzano- Milan, Italy;(9)IRCCS Humanitas Research Hospital, Colon and Rectal Surgery Unit, Rozzano- Milan, Italy;(10)Humanitas Clinical and Research Center-IRCCS, Digestive Endoscopy Unit- Department of Gastroenterology, Rozzano- Milan, Italy;
N02: Inflammatory bowel disease patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomized controlled trial in Germany (IBDBIO-ASSIST study) - The IBD nurses perspectiveECCO'24Year: 2024
Authors: Hartmann, P.(1)*;Zemke, J.(2);Plachta-Danielzik, S.(3,4);Steiner, I.M.(5);Pohlschneider, D.(6);Urzica, E.(6);Tappe, U.(7);Schreiber, S.(8);Steinkat, N.(9);Langbrandtner, J.(10,11);Hüppe, A.(12);Stargardt, T.(13);Bokemeyer, B.(6,14);
(1)Gastroenterology Practice, Department of Gastroenterology, Minden, Germany;(2)Gastroenterology Practice, Department of Gastroenterology, Herne, Germany;(3)Competence Network IBD, IBD Oganisation, Kiel, Germany;(4)Christian-Albrechts University- Kiel, Institute of Human Nutrition and Food Science, Kiel, Germany;(5)University of Hamburg, Center of Health Economics, Hamburg, Germany;(6)Competence Network IBD, IBD Organisation, Kiel, Germany;(7)Gastroenterology Practice, Department of Gastroenterology, Hamm, Germany;(8)University Hospital Schleswig-Holstein- Campus Kiel, Clinic of General Internal Medicine, Kiel, Germany;(9)Techniker Krankenkasse, Health insurance, Hamburg, Germany;(10)University of Lübeck, Institute of Social Medicine and Epidemiology, Lübeck, Germany;(11)University of Lübeck, Center for Population Medicine and Health Services Research, Lübeck, Germany;(12)University of Lübeck, Institute of Social Medicine and Epidemiology-, Lübeck, Germany;(13)University of Hamburg, Hamburg Center for Health Economics, Hamburg, Germany;(14)University Hospital Schleswig-Holstein- Campus Kiel, of General Internal Medicine I, Kiel, Germany;
N03: Flexibility & Accessibility, e-Literacy, Resourcing and The Human Factor: Early Lessons from EIBD, a UK Qualitative Interview StudyECCO'24Year: 2024
Authors: Avery, P.(1)*;Kemp, K.(2);Dibley, L.(3);Green, S.(4);
(1)Bournemouth University, Nursing Science, Bournemouth, United Kingdom;(2)Manchester Royal Infirmary, Gastroenterology IBD, Manchester, United Kingdom;(3)The Univerisity of Greenwich, Centre for Chronic Illness and Ageing, London, United Kingdom;(4)Bournemouth University, Nursing Sciences, Bournemouth, United Kingdom;
N04: Impact of phase angle on nutritional assessment and disease activity in patients with Ulcerative ColitisECCO'24Year: 2024
Authors: Bueno Hernández, N.(1)*;Viridiana Montsserrat, M.M.(2);Javier Ivanovychs , C.R.(3);Francisca , M.S.(4);Jorge , D.L.R.(5);
(1)General Hospital of Mexico Dr. Eduardo Licega, Research division, Mexico City-, Mexico;(2)General Hospital of Mexico, Infammatory Bowel Disease Clinic, Mexico City, Mexico;(3)Centro Medico La Raza, Gastroenterología, Mexico City, Mexico;(4)Centro Médico La Raza, Gastroenterologia, Mexico City, Mexico;(5)General Hospital of Mexico, Inflammatory Bowel Disease Clinic, Mexico City, Mexico;
N06: Self-care in patients affected by inflammatory bowel disease: SELF-IBD observational study in a single centerECCO'24Year: 2024
Authors: Napolitano, D.(1,2)*;Schiavoni, E.(2);Amatucci, V.(2);Monaci, A.(1,3);Martella, P.(1,3);Orgiana, N.(4);Benini, V.(2);Di Massimo, A.(2);Turchini, L.(2);Giordano, L.N.(2);Conticelli, C.(2);Pettinari, V.(2);De Vito, A.(2);Virone, C.(2);Lorusso, A.(2);Fanali, C.(2);Ribaudi, E.(2);Bernabei, T.(2);Gasbarrini, A.(2,5);Scaldaferri, F.(2,5);Cocchieri, A.(5);
(1)Tor Vergata University, Tor Vergata University, Rome, Italy;(2)Fondazione Policlinico Gemelli IRCCS, Cemad, Rome, Italy;(3)Fondazione Policlinico Gemelli IRCCS, Ticc, Rome, Italy;(4)Fondazione Policlinico Gemelli IRCCS, Cut, Rome, Italy;(5)Università Cattolica del Sacro Cuore, Università Cattolica del Sacro Cuore, Rome, Italy;
N07: JAKne: JAK inhibitor associated acne, a real-life single-center experience.ECCO'24Year: 2024
Authors: De Dycker, E.(1)*;Vermeire, S.(1);Ferrante, M.(1);Lambrechts, T.(1);Paps, A.(1);Geens, P.(1);Loddewijkx, E.(1);Sabino, J.(1);Hillary, T.(2);Verstockt, B.(1);
(1)University Hospitals Leuven Belgium, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)University Hospitals Leuven Belgium, Department of Dermatology, Leuven, Belgium;
N09: Transition Success Score as a valid quantitative measure to evaluate the effect of transitional care in IBD patientsECCO'24Year: 2024
Authors: van Gaalen, M.(1)*;van Pieterson, M.(1);de Ridder, L.(1);Derikx, L.(2);Escher, J.(1);
(1)Erasmus Medical Center Children@E@s Hospital, Department of Paediatrics- Children@E@s Gastroenterology, Rotterdam, The Netherlands;(2)Erasmus MC, Gastroenterology, Rotterdam, The Netherlands;
N10: Evaluation of the impact of an IBD nurse in an Inflammatory Bowel Disease CenterECCO'24Year: 2024
Authors: Rachart, A.(1);Cluzeau, V.(1);Martins, C.(2)*;Hebuterne , X.(1);Nicolau, A.(1);
(1)CHU de Nice, Gastroenterology, Nice, France;(2)APHP, Gastroenterology, Paris, France;
N11: The effect of progressive relaxation techniques on disease activity, anxiety, sleep, and quality of life in individuals with Ulcerative ColitisECCO'24Year: 2024
Authors: Artan, Y.(1)*;Yıldırım, Y.(2);Unal, N.G.(3);
(1)Ardahan University, Internal Medicine Nursing, Ardahan, Turkey;(2)Ege University, Internal Medicine Nursing, Izmir, Turkey;(3)Ege University, Internal Medicine/ Gastroenterology, Izmir, Turkey;
N13: Sexual satisfaction and its associated factors among patients with inflammatory bowel disease in JapanECCO'24Year: 2024
Authors: Wakai, S.(1);Tanaka, M.(2)*;Takai, M.(1);Sakagami, K.(3);Hiroaki, I.(3);
(1)Tokyo Medical and Dental University TMDU, Dep. Adult Health Nursing, Tokyo, Japan;(2)Tokyo Medical and Dental University TMDU- Graduate School of Health Care Sciences-, Dep. Adult Health Nursing, Tokyo, Japan;(3)Kinshukai Infusion Clinic, Gastroenterology, Osaka, Japan;
N15: Developing a Tool for educating newly diagnosed Patients with Inflammatory Bowel Disease based on a Quality Database Indicator.ECCO'24Year: 2024
Authors: Kjaer-Mikkelsen, E.(1)*;Edelbo, R.(2);Riddersholm, C.(3);Blichfeldt, B.(4);Krogager, Y.(4);Andersen, D.V.(5);Berg, A.(3);
(1)Regional Hospitalet Gødstrup, Clinic of gastroenterology, Herning, Denmark;(2)Aarhus University Hospital, Department of gastroenterology, Aarhus, Denmark;(3)Odense University Hospital, Department of Gastroenterology, Odense, Denmark;(4)Herlev Hospital, Department of gastroenterology, Copenhagen, Denmark;(5)Aalborg University Hospital, Department of Gastroenterology, Aalborg, Denmark;
